DE69435002T2
(de)
|
1993-07-19 |
2008-03-20 |
Angiotech Pharmaceuticals, Inc., Vancouver |
Anti-angiogene Mittel enthaltend Taxol und einen nicht biodegradierbaren Träger und deren Verwendung
|
US5994341A
(en)
*
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
US5681846A
(en)
*
|
1995-03-17 |
1997-10-28 |
Board Of Regents, The University Of Texas System |
Extended stability formulations for paclitaxel
|
US6245805B1
(en)
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US6395770B1
(en)
|
1995-10-26 |
2002-05-28 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for administering taxanes orally to human patients
|
WO1997023208A1
(en)
*
|
1995-12-21 |
1997-07-03 |
Genelabs Technologies, Inc. |
Taxane composition and method
|
KR100191446B1
(ko)
*
|
1996-05-02 |
1999-06-15 |
송영욱 |
파클리탁셀 함유 전신성 홍반성 낭창치료제
|
CN1219872A
(zh)
*
|
1996-05-24 |
1999-06-16 |
血管技术药物公司 |
治疗或预防身体通道疾病的组合物和方法
|
KR100330373B1
(ko)
*
|
1996-05-28 |
2002-11-07 |
주식회사한국신약 |
탁솔을 함유한 주사용 약제 조성물
|
US5877205A
(en)
*
|
1996-06-28 |
1999-03-02 |
Board Of Regents, The University Of Texas System |
Parenteral paclitaxel in a stable non-toxic formulation
|
KR100358934B1
(ko)
*
|
1996-09-13 |
2003-01-29 |
주식회사한국신약 |
탁솔을함유한주사용약제조성물
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
CA2628857C
(en)
|
1996-12-30 |
2011-09-13 |
Batelle Memorial Institute |
Formulation and method for treating neoplasms by inhalation
|
CA2288306A1
(en)
|
1997-04-28 |
1998-11-05 |
Rhone-Poulenc Rorer S.A. |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
CN1101677C
(zh)
*
|
1997-05-30 |
2003-02-19 |
韩万愚 |
含有紫杉醇的药用注射溶液
|
EP0998279B1
(de)
*
|
1997-05-30 |
2002-10-16 |
Man Woo Han |
Taxol enthaltende pharmazeutische injektionslösung
|
BE1011216A3
(fr)
*
|
1997-06-13 |
1999-06-01 |
Thissen En Abrege L T B Lab |
Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
|
US5925776A
(en)
*
|
1997-12-24 |
1999-07-20 |
Schein Pharmacetical, Inc. |
Polyethoxylated castor oil, process of making the same and formulations thereof
|
GB9803448D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Pharma Mar Sa |
Pharmaceutical formulation
|
US5922754A
(en)
*
|
1998-10-02 |
1999-07-13 |
Abbott Laboratories |
Pharmaceutical compositions containing paclitaxel
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
EP2266607A3
(de)
|
1999-10-01 |
2011-04-20 |
Immunogen, Inc. |
Immunokonjugate für Krebsbehandlung
|
RU2261104C2
(ru)
*
|
1999-11-15 |
2005-09-27 |
Фарма Мар С.А. |
Лечение злокачественных опухолей аплидином
|
CZ20013498A3
(cs)
*
|
2000-02-02 |
2002-04-17 |
Florida State University Research Foundation, Inc. |
Taxanové formulace mající zlepąenou rozpustnost
|
KR20010100194A
(ko)
*
|
2000-03-13 |
2001-11-14 |
박호군 |
여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법
|
JP2004536026A
(ja)
*
|
2000-11-28 |
2004-12-02 |
トランスフォーム ファーマシューティカルズ,インコーポレーティッド. |
パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
|
JP2005504070A
(ja)
*
|
2001-09-13 |
2005-02-10 |
コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー |
化学塞栓用油性パクリタキセル組成物及び処方物並びにその製造方法
|
DE60229414D1
(de)
*
|
2001-10-19 |
2008-11-27 |
Pharma Mar Sa |
Verwendung von aplidine in der behandlung von pankreaskrebs
|
US20040092428A1
(en)
*
|
2001-11-27 |
2004-05-13 |
Hongming Chen |
Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
|
ATE515277T1
(de)
*
|
2002-05-24 |
2011-07-15 |
Angiotech Int Ag |
Zusammensetzungen und verfahren zum beschichten von medizinischen implantaten
|
US8313760B2
(en)
|
2002-05-24 |
2012-11-20 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
ES2666694T3
(es)
|
2002-09-06 |
2018-05-07 |
Cerulean Pharma Inc. |
Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
|
US20080220074A1
(en)
*
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
WO2006055008A2
(en)
*
|
2003-11-20 |
2006-05-26 |
Angiotech International Ag |
Implantable sensors and implantable pumps and anti-scarring agents
|
PT1792927E
(pt)
*
|
2004-09-22 |
2013-05-15 |
Nippon Kayaku Kk |
Novo copolímero em bloco, preparação de micelas e agente anticancerígeno contendo o mesmo como ingrediente activo
|
AU2005100176A4
(en)
*
|
2005-03-01 |
2005-04-07 |
Gym Tv Pty Ltd |
Garbage bin clip
|
CA2611592A1
(en)
|
2005-06-17 |
2006-12-21 |
Hospira Australia Pty Ltd |
Liquid pharmaceutical formulations of docetaxel
|
GB0517092D0
(en)
*
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
BRPI0600194A
(pt)
|
2006-01-30 |
2007-10-23 |
Quiral Quimica Do Brasil S A |
composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
|
CN101023940A
(zh)
*
|
2006-02-20 |
2007-08-29 |
郝守祝 |
一种紫杉烷类化合物的药用组合物、制备方法及用途
|
JP5249016B2
(ja)
|
2006-03-28 |
2013-07-31 |
日本化薬株式会社 |
タキサン類の高分子結合体
|
US8940332B2
(en)
|
2006-05-18 |
2015-01-27 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of podophyllotoxins
|
WO2008041610A1
(fr)
*
|
2006-10-03 |
2008-04-10 |
Nippon Kayaku Kabushiki Kaisha |
Mélange d'un dérivé de résorcinol avec un polymère
|
JP5503872B2
(ja)
|
2006-11-06 |
2014-05-28 |
日本化薬株式会社 |
核酸系代謝拮抗剤の高分子誘導体
|
EP2090607B1
(de)
|
2006-11-08 |
2015-05-20 |
Nippon Kayaku Kabushiki Kaisha |
Polymerderivat eines nukleinsäuremetabolismus-antagonisten
|
EP2115173B1
(de)
|
2007-01-08 |
2011-09-21 |
Government of the USA, as Represented by the Secretary, Department of Health and Human Services |
Slco1b3-genotyp
|
CZ200756A3
(cs)
*
|
2007-01-23 |
2008-07-30 |
Heaton, A. S. |
Dvousložková farmaceutická kompozice obsahující taxan
|
US20080176958A1
(en)
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
CN101244053B
(zh)
*
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术(石家庄)有限公司 |
以多西他赛为主组分的新的分散体系
|
EP2146695A4
(de)
*
|
2007-04-23 |
2010-05-19 |
Sun Pharmaceuticals Ind Ltd |
Pharmazeutische zusammensetzungen
|
AU2008269179A1
(en)
*
|
2007-06-22 |
2008-12-31 |
Scidose Llc |
Solubilized formulation of docetaxel without Tween 80
|
USRE46190E1
(en)
|
2007-09-28 |
2016-11-01 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of steroids
|
CN101396354B
(zh)
*
|
2007-09-30 |
2010-12-01 |
江苏恒瑞医药股份有限公司 |
一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用
|
WO2009047794A2
(en)
*
|
2007-10-01 |
2009-04-16 |
Intas Pharmaceuticals Limited |
Taxane derivative composition
|
AR063111A1
(es)
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
FR2922107B1
(fr)
*
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
WO2009113989A1
(en)
|
2008-03-14 |
2009-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Compositions and methods of use of compounds to increase cancer patient survival time
|
DK2249825T3
(en)
|
2008-03-14 |
2016-01-11 |
Bionumerik Pharmaceuticals Inc |
Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
|
KR101589582B1
(ko)
*
|
2008-03-18 |
2016-01-28 |
니폰 가야꾸 가부시끼가이샤 |
생리활성물질의 고분자량 결합체
|
NZ602675A
(en)
|
2008-03-18 |
2014-03-28 |
Genentech Inc |
Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
|
WO2009136572A1
(ja)
|
2008-05-08 |
2009-11-12 |
日本化薬株式会社 |
葉酸若しくは葉酸誘導体の高分子結合体
|
ES2344674B1
(es)
|
2008-08-07 |
2011-06-29 |
Gp Pharm, S.A. |
Composicion farmaceutica inyectable de taxanos.
|
AU2009282413B2
(en)
|
2008-08-11 |
2014-07-17 |
Nektar Therapeutics |
Multi-arm polymeric alkanoate conjugates
|
US8541360B2
(en)
*
|
2008-11-19 |
2013-09-24 |
Ben Venue Laboratories, Inc. |
Parenteral formulations comprising sugar-based esters and ethers
|
MX2011009413A
(es)
|
2009-03-11 |
2011-10-21 |
Ambit Biosciences Corp |
Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer.
|
EP2431403B1
(de)
|
2009-05-15 |
2016-09-28 |
Nipponkayaku Kabushikikaisha |
Polymerkonjugat aus einer bioaktiven substanz mit einer hydroxidgruppe
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
EP2493466B1
(de)
|
2009-10-29 |
2021-03-10 |
Sanofi Mature IP |
Neue antitumorale verwendung von cabazitaxel
|
CN104208716A
(zh)
*
|
2009-11-23 |
2014-12-17 |
天蓝制药公司 |
用于传递治疗剂的基于环糊精的聚合物
|
US20110165155A1
(en)
|
2009-12-04 |
2011-07-07 |
Genentech, Inc. |
Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1
|
CN102791715B
(zh)
|
2009-12-31 |
2016-04-27 |
卡洛斯三世国家癌症研究中心基金会 |
用作激酶抑制剂的三环化合物
|
CA2787714C
(en)
|
2010-01-22 |
2019-04-09 |
Joaquin Pastor Fernandez |
Inhibitors of pi3 kinase
|
CN102947302A
(zh)
|
2010-02-18 |
2013-02-27 |
西班牙国家癌症研究中心 |
三唑并[4,5-b]吡啶衍生物
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
WO2011121317A1
(en)
|
2010-04-01 |
2011-10-06 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazo [2,1-b] [1,3,4] thiadiazoles as protein or lipid kinase inhibitors
|
KR101752944B1
(ko)
|
2010-05-03 |
2017-07-03 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법
|
WO2012052745A1
(en)
|
2010-10-21 |
2012-04-26 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Combinations of pi3k inhibitors with a second anti -tumor agent
|
EP2641605B1
(de)
|
2010-11-17 |
2018-03-07 |
Nippon Kayaku Kabushiki Kaisha |
Polymerderivat für einen cytidinstoffwechselantagonisten
|
WO2012088422A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
US10894087B2
(en)
|
2010-12-22 |
2021-01-19 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
KR20140025434A
(ko)
|
2011-04-01 |
2014-03-04 |
제넨테크, 인크. |
Akt 억제제 화합물 및 화학요법제의 조합물, 및 사용 방법
|
WO2012156999A1
(en)
|
2011-05-19 |
2012-11-22 |
Manu Chaudhary |
Ready to use docetaxel formulation
|
RU2598840C2
(ru)
|
2011-05-19 |
2016-09-27 |
Фундасион Сентро Насиональ Де Инвестигасионес Онколохикас Карлос Iii |
Новые соединения
|
EP2524918A1
(de)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazinderivate als Kinase Inhibitoren
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
WO2013004984A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Tricyclic compounds for use as kinase inhibitors
|
WO2013005041A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Tricyclic heterocyclic compounds as kinase inhibitors
|
RS58146B1
(sr)
|
2011-09-08 |
2019-02-28 |
Univ New York |
Onkolitički herpes simpleks virus i njegova terapeutska upotreba
|
EP2754682B1
(de)
|
2011-09-11 |
2017-06-07 |
Nippon Kayaku Kabushiki Kaisha |
Verfahren zur herstellung von blockcopolymer
|
WO2013096455A1
(en)
|
2011-12-20 |
2013-06-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
AU2013266243A1
(en)
|
2012-05-24 |
2014-12-18 |
Beth Israel Deaconess Medical Center, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
|
WO2013182668A1
(en)
|
2012-06-08 |
2013-12-12 |
F. Hoffmann-La Roche Ag |
Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
|
US20150285802A1
(en)
|
2012-07-18 |
2015-10-08 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
WO2014055493A1
(en)
|
2012-10-02 |
2014-04-10 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
EP2968406A4
(de)
|
2013-03-14 |
2016-10-26 |
Icahn School Med Mount Sinai |
Mit autologem tumorlysat beladener dendritischer zellimpfstoff zur behandlung von leberkrebs
|
US10130590B2
(en)
|
2013-10-01 |
2018-11-20 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
CA2942101A1
(en)
|
2014-03-21 |
2015-09-24 |
Abbvie Inc. |
Anti-egfr antibodies and antibody drug conjugates
|
WO2015149006A2
(en)
|
2014-03-27 |
2015-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
US10967015B2
(en)
|
2015-06-15 |
2021-04-06 |
New York University |
Method of treatment using oncolytic viruses
|
US10188626B2
(en)
|
2015-11-03 |
2019-01-29 |
Cipla Limited |
Stabilized cabazitaxel formulations
|
CA3027046A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
CN109641962A
(zh)
|
2016-06-08 |
2019-04-16 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
BR112018075653A2
(pt)
|
2016-06-08 |
2019-08-27 |
Abbvie Inc |
anticorpos anti-b7-h3 e conjugados anticorpo fármaco
|
AU2017277914A1
(en)
|
2016-06-08 |
2019-01-03 |
Abbvie Inc. |
Anti-CD98 antibodies and antibody drug conjugates
|
IL300274A
(en)
|
2016-06-08 |
2023-04-01 |
Abbvie Inc |
Antibodies against B7–H3 and conjugates of drug and antibody
|
AU2018328532A1
(en)
|
2017-09-07 |
2020-04-23 |
Ningbo Combireg Pharmaceutical Technology Co., Ltd |
Pharmaceutical composition of docetaxel conjugate and preparation method
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|